Dr. Krina Chavda, DO

Dr. Chavda practices at Bay Dermatology and Cosmetic Surgery P A in Port Richey, Florida.

Dr. Chavda's NPI, 1831424142, was assigned on October 5, 2009. Dr. Chavda graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2004. Dr. Chavda holds New York license 246608-1.

Dr. Chavda's primary practice is Bay Dermatology and Cosmetic Surgery P A, at 8220 Us-19, Port Richey, FL 34668 in Pasco County. The practice phone is (727) 841-8505.

Dr. Chavda's primary practice is Bay Dermatology and Cosmetic Surgery P A in Port Richey, Florida. The medical group on file is Bay Dermatology and Cosmetic Surgery. Dmand AI also links Dr. Chavda to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chavda practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Chavda's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Chavda is board certified in dermatology by the AOA Board of Dermatology. Dr. Chavda is licensed in New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and hives among the conditions Dr. Chavda treats.

CMS data shows 15,080 Medicare services from Dr. Chavda across 22 procedure codes in 2024, for 756 Medicare patients. Medicare paid $209,252 for them. Every service was in an office.

CMS counts 756 Medicare patients who saw Dr. Chavda in 2024. The largest group is 65 to 74, with 407 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chavda's median patient age at 68, with 60% women.

In 2024, Dr. Chavda wrote 1,088 Medicare Part D claims for 477 patients. 93% of them were for generic drugs. CMS names the drug for 973 of them, across 22 drugs with 11 or more claims each, at $263,155 in total drug cost. In 2023, CMS named 796 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Chavda for performance year 2024, reported individually. Dr. Chavda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,633 procedures of removal of skin lesions by Dr. Chavda, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Chavda, published from 2021 to 2023. 2021 was the busiest year, with 2. Dr. Chavda has published most often in JAAD Case Rep. Dr. Chavda's most frequent co-authors are Richard A. Miller, DO, Richard George Bindernagel, DO and Keith Edward Baribault, MD.

CMS Open Payments shows 851 general payments to Dr. Chavda from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Novartis Pharmaceuticals Corporation paid the most, $4,579.

Dr. Chavda graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2004. Dr. Chavda is a member of AOA and ASDS.

Dr. Chavda is in network with 17 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.